Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy Vaccine

NCT00118625 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Type I Hypersensitivity

Interventions

BIOLOGICAL: Tree MATA MPL

Sponsor

Allergy Therapeutics